Several Patients Overdosed with Antibiotics during Cataract Procedure

A number of patients undergoing cataract surgery at the Mount Stuart Hospital in Torquay received an overdose of antibiotics during surgery on their cataracts, and as such will likely be entitled to a claim for compensation.

When two patients arrived at the Accident and Emergency Department at the Torbay Hospital on the same day with problems concerning their eyesight, it was noted that both patients underwent cataract surgery on the same day that July. This observation launched an investigation, where it was discovered that the patients had both been given an overdose of antibiotics during the procedure.

The hospital where the surgery occurred, Mount Stuart, immediately stopped preforming the procedure and launched an internal investigation. All nineteen individuals who had undergone the surgery on the 26th July were called in to the hospital for a review. No corrective surgery was needed, though two patients were “seriously harmed” by the overdose, and four others “showed symptoms” of damage.

It was uncovered that the antibiotic had been diluted for sub-conjuntive use (use below the clear layer over the eye), yet had been given intracamerally (into a section of the eye that was much deeper). Though the antibiotic was suitable for use in both locations, the concentration would not have been the same for both.

Human error was cited for the mix-up, and the consultant surgeon, their assistant and a circulating practitioner were all suspended from the hospital. The procedure has been resumed at Mount Stuart Hospital.

A spokesperson for the South Devon and Torbay Clinical Commissioning Group has stated that “We are satisfied that the hospital has learned important lessons from this incident and that it has acted swiftly to make the necessary changes that will ensure future safety for patients.”

Read More

Health Trust offers Cancer Patients Compensation for Lack of Care

The Surrey and Sussex Healthcare NHS Trust is offering cancer patients compensation for a lack of care following an investigation into the standard of care provided by a consultant urologist.

Twenty-seven patients of the East Surrey Hospital in Redhill are believed to have suffered avoidable side effects related to their care, or have experienced an avoidable progression of their disease, due to a lack of care by consultant urologist Paul Miller, who worked at the hospital between 2006 and 2013.

According to the results of an internal investigation, the patients – who are all suffering from bladder cancer or prostate cancer – were not given the full range of options available to them or informed of the consequences, and subsequently they were provided with treatments that may not have been in their best interests and due to which there is a higher likelihood of the cancer returning.

The investigation into the lack of care provided by Paul Miller was launched after concerns were raised by colleagues and specialist nurses at the East Surrey hospital last November. Dr Miller was suspended the following month while an investigation into the standard of care provided to patients took place, and he was subsequently dismissed from his post earlier this year.

More than one thousand letters have been sent to patients under the care of Mr Miller, with the NHS Trust offering the twenty-seven affected cancer patients compensation for a lack of care. The NHS Trust has also established a helpline for concerned patients – 0808 168 7754 – which is manned between 11:00am and 7:00pm from Monday to Friday.

Speaking about the offer to cancer patients of compensation for a lack of care, Michael Wilson – Chief Executive of Surrey and Sussex Healthcare NHS Trust – said that Mr Miller had not “followed the advice of multi-disciplinary teams in carrying out established and recognised cancer treatments”. He added that the letters sent to each of the patients were “to enable compensation to be considered and paid”.

In addition to working at the East Surrey Hospital, Mr Millar was also employed at the Spire Gatwick Park Hospital in Horley. The hospital´s director – John Crisp – said that Mr Miller had not undertaken any surgery or held clinics at the hospital since his suspension in December. Mr Miller is also subject to a formal investigation by the General Medical Council.

Read More

Faulty Hip System DePuy “Poster Girl” Take Negligence Compensation Case

A retired gymnast, who promoted the DePuy ASR Hip Replacement System before to the product´s worldwide recall last year, is making a negligence compensation claim against the product´s manufacturers Johnson & Johnson following difficulties with her own DePuy hip replacement system.

Penny Brown (51) of Bath, Wiltshire, had hip replacement surgery in 2004 to relieve her from the constant pain of osteoarthritis. At the time of the surgery, the DePuy ASR hip replacement system transformed her daily life to such a degree that she agreed to become the “face” of DePuy and promote their hip replacement systems throughout the UK.

Between 2004 and 2008, Penny was DePuy’s “patient brand” and her image was used all over the world. Penny also gave interviews about the benefits of the DePuy ASR hip replacement device and counselled patients about to have implant surgery. However, in 2009, Penny began to develop a groin pain which was diagnosed as being caused by the hip replacement system and, as the wear and tear grew, felt a clunking sensation whenever she walked anywhere.

In May 2011, Penny was informed that she would need revision surgery which would mean the removal of the DePuy ASR hip replacement device and a replacement system installed.  She had her operation and has been bed-bound and not able to work ever since.


Read More

Claim for Blood Poisoning Injury Made for DePuy Medication Error

A claim for medication error injury has been made against DePuy Orthopaedics by a woman who received her DePuy ASR hip replacement system as recently as November 2009.

The medication error claim, made by Delores Hatcher from Wheeling, West Virginia, follows the results of a blood test in April 2011 which indicated high levels of chromium-1 and meta-cobalt in her blood – known causes of cardiovascular injury and neurological conditions such as headaches, confusion and cognitive decline, and possibly carcinogens which could lead to the development of cancer.

Delores added her medication error claim to the growing number of compensation claims following the DePuy hip recall of August 2010 after visiting her doctor complaining of pain around her left hip and difficulty in walking. Both Delores and her doctor were overcome by the outcome of the blood tests as the hip replacement was fitted in November 2009 and had failed in a short period of time.

In her claim for blood poisoning compensation from medication error, Delores also accuses Johnson & Johnson – the parent company of DePuy Orthopaedics – of hiding known defects with the faulty hip replacement systems and alleges that they aggressively marketed the faulty hip replacement systems by paying kickbacks to medical supplies purchasers and orthopaedic surgeons.

Read More